TickerFactsScreenerDevelopers

CRISPR Therapeutics AG (CRSP) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2015: $1.15M2016: $3.02M2017: $7.81M2018: $2.77M2019: $6.68M2020: $18.36M2021: $81.70M2022: $37.19M2023: $9.47M2024: $1.90M2025: $914.0K$914.0K
2015Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$914.0K-51.9%
2024$1.90M-79.9%
2023$9.47M-74.5%
2022$37.19M-54.5%
2021$81.70M+345.1%
2020$18.36M+174.7%
2019$6.68M+141.0%
2018$2.77M-64.5%
2017$7.81M+159.1%
2016$3.02M+161.4%
2015$1.15M—